2.574
2.70%
+0.0677
Handel nachbörslich:
2.574
Innate Pharma ADR Aktie (IPHA) Neueste Nachrichten
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress - Investing.com
Investing.com
All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy
Zacks Investment Research
IPHA Stock Quote Price and Forecast - CNN
CNN
Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study
Zacks Investment Research
Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities News
Equities News
Kapitalisierung:
|
Volumen (24h):